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Abstract: Background: The problems in sexual functioning among patients with post-traumatic stress
disorder (PTSD) are often overlooked, although scientific research confirms high rates of sexual
dysfunctions (SD) particularly among veterans with PTSD. The main objective of this study was
to systematically identify predictors of SD among veterans with PTSD. Methods: Three hundred
veterans with PTSD were included in the cross-sectional study. The subjects were assessed by the
Mini-International Neuropsychiatric Interview (MINI) and self-report questionnaires: PCL-5, i.e.,
PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
with Criterion A, International Index of Erectile Function (IIEF), Premature Ejaculation Diagnostic
Tool (PEDT), and Relationship Assessment Scale (RAS). Several hierarchical multiple regressions
were performed to test for the best prediction models for outcome variables of different types of SD.
Results: 65% of participants received a provisional diagnosis of SD. All tested prediction models
showed a good model fit. The significant individual predictors were cluster D (Trauma-Related
Negative Alterations in Cognition and Mood) symptoms (for all types of SD) and in a relationship
status/relationship satisfaction (all, except for premature ejaculation (PE)). Conclusions: The most
salient implication of this study is the importance of sexual health assessment in veterans with PTSD.
Therapeutic interventions should be focused on D symptoms and intended to improve relationship
functioning with the aim to lessen the rates of SD. Psychotropic treatment with fewer adverse sexual
effects is of utmost importance if pharmacotherapy is applied. Appropriate prevention, screening,
and treatment of medical conditions could improve sexual functioning in veterans with PTSD.
Keywords: post-traumatic stress disorder; sexual dysfunction; veterans; predictors
1. Introduction
The problems in sexual functioning among patients with post-traumatic stress disorder (PTSD)
are often overlooked clinically and receive little attention in research. However, an increasing body of
scientific research regarding sexual dysfunctions (SD) among veterans who were exposed to military
trauma confirms much higher rates of problems in sexual functioning among veterans with PTSD
than in those without PTSD or in adults without exposure to military trauma [1–5]. The rates of SD
differ across the studies, mainly because of methodological differences. Systematic reviews reported a
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prevalence of SD between 8.4% and 88.6% among male veterans with PTSD [3,5]. Persons with PTSD,
compared with similarly exposed survivors without it, have an increased risk of SD implying that
PTSD, rather than trauma exposure per se, is the more proximal antecedent to sexual problems [3,6–10].
Studies revealed correlation of PTSD with a variety of impairments in the specific domains of sexuality
(desire, arousal, orgasm, resolution) [1–7]. On the other hand, the specific PTSD symptoms or PTSD
symptom clusters may influence the prevalence of SD unevenly. The emotional numbing and avoidance
cluster, for example, appeared to be intimately tied to impairment in sexual functioning and higher
level of sexual anxiety [2,11,12].
1.1. Predictors of Sexual Dysfunction in Veterans with PTSD
Only a few studies and systematic reviews have addressed the possible predictors that have an
impact on sexual functioning in the population of veterans with or without PTSD. Considering
the relationship between overall PTSD symptom severity and SD, studies revealed conflicting
results [5]. Particular PTSD clusters and symptoms have been studied, and it was hypothesized
that autonomic arousal, anger/hostility [13], emotional numbing/avoidance symptoms [2,11,12], and
chronic autonomic arousal and intrusive symptoms [3,14,15] were mostly associated with sexual
problems among veterans with PTSD. Recent studies indicate that emotional numbing may impede
intimacy and attachment, thus serving as a potential mechanism through which symptoms of PTSD
may drive problems and predict SD in these patients. According to the Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition (DSM-5) [16], numbing symptoms (low positive emotions
and negative emotional state) were included in the new D symptom cluster (Trauma-Related Negative
Alterations in Cognition and Mood). These and other symptoms from this cluster, such as diminished
interest or participation in significant activities, a feeling of detachment or estrangement from
others, and guilt and shame, may impede sexual functioning in veterans with PTSD. SD is more
common among veterans who are male, older, separated, divorced, or widowed, have lower annual
income, mental health diagnoses—particularly PTSD—hypertension, and are prescribed psychiatric
medications [1,4,17]. Returning combat veterans with SD have a reduced quality of life, decreased
sexual intimacy, and increased health-care utilization [18]. PTSD is associated with impairments
in romantic relationship satisfaction [19,20]. Recent research revealed that marital dissatisfaction
is the factor that mediates the relationship between the number of PTSD symptoms and sexual
dissatisfaction [21]. Considering the specific types of SD, age appeared to be the only significant
predictor of erectile dysfunction; age, race, depression, and social support predicted self-reported
sexual arousal problems; and race, combat exposure, social support, and avoidance/numbing
symptoms of PTSD predicted self-reported sexual desire problems in male combat veterans seeking
outpatient treatment for PTSD [2].
1.2. Predictors of Sexual Dysfunction in the General Population
Generally speaking, the predictors, risk, or etiological factors of SD can be separated in two
groups: “organic” (such as diabetes, peripheral vascular disease or venous leaks, injury of the spinal
cord, etc.) and “non-organic” (such as anxiety, depression, cultural taboos, ignorance, relationship
problems, poor communication skills, etc.). However, there is substantial evidence indicating a
multifactorial etiology of sexual function and dysfunction, meaning that the sexual response can be
described as a complex interaction of psychological, interpersonal, social, cultural, physiological, and
gender-influenced processes [22,23]. SD is strongly associated with certain health conditions and
diseases, psychiatric disorders, medication or substance use, lack of knowledge, psychological or
behavioral factors, relationship and cultural factors processes [23].
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1.3. Study Background
More than 20 years after the Homeland War in Croatia (1991–1995), veterans still suffer from
numerous health problems. Patients and/or health professionals may be reluctant to mention and
discuss sexual symptoms [24], and a huge proportion of SD remains undiagnosed. Despite that, clinical
observations and rising awareness have encouraged the recognition and assessment of SD in this
patient group, and case reports [25] and research articles [26,27] regarding SD in veterans with PTSD
in Croatia have been published.
The main objective of this research is to systematically identify predictors of SD among veterans
with PTSD. The main hypothesis of the study is that SD are predicted by overall PTSD symptom
severity and by severity of D symptom cluster (Trauma-Related Negative Alterations in Cognition and
Mood).
2. Experimental Section
2.1. Participants and Procedure
Participants were male war veterans (N = 300) recruited from a pool of patients referred to the
Regional Center for Psychotrauma (RCP) and Department of Psychiatry within the Clinical Hospital
Center (CHC) Rijeka, the Referral Center for PTSD of the Ministry for Health of the Republic of Croatia
(N = 250), and the Daily Hospital for PTSD and Department of Psychiatry within the General Hospital
(GH) Našice for treatment. Most of the veterans participated in operations on different and almost all
battlefields. Thirteen of those whom we approached refused to participate, while two patients did not
complete the questionnaires.
Eligibility was determined by meeting diagnostic criteria for war-related PTSD as defined in
DSM-5 [16]. Three patients were not eligible for the study as they did not meet the criteria for PTSD
diagnosis. We continued recruiting patients until the number of 300 participants was reached. There
were no differences in sociodemographic characteristics between those who refused to participate,
those who did not complete the questionnaires, and those who were not eligible for the study.
The inclusion criteria for the study were: participation in the Homeland War as a soldier,
experiencing at least one war-related traumatic event defined in the DSM-5 criteria for PTSD (personal
experience of combat or exposure to a war zone), male gender, and age below 65. The exclusion criteria
for the study were: active psychosis, moderate or high suicide risk measured by the Mini-International
Neuropsychiatric Interview (MINI) for DSM-IV [28], and deformities, injury, or mutilation of the
genital organs. None of the participants met the exclusion criteria.
Research consisted of two parts, i.e., a clinical interview and self-report questionnaires.
The interviews were conducted by five psychiatrists and two psychologists from the two study
sites. Sociodemographic data were collected through a questionnaire created for study purposes.
The interviews and filling in of the questionnaires were usually completed in one or two sessions.
The study was approved by the Ethics Committees of the Faculty of Medicine, University of Rijeka,
CHC Rijeka, and GH Našice. Written informed consent was obtained from all participants after
detailed information about the study was provided to them.
The study sample included a total of 300 male veterans. At the time of participation in the
study, the majority of participants were in ambulatory treatment (66.8%), while other participants
were involved in day-hospital treatment (19.3%) or club for PTSD (7.5%), or were hospitalized (6.4%).
Table 1 provides further information on sample demographics.
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Table 1. Sociodemographic characteristic and differences according to the presence of
sexual dysfunction.
All
n = 300
Sexual
Dysfunction
NO
n = 98
Sexual
Dysfunction
YES
n = 181
Statistics Probability
M(sd) or N(%) M(sd) or N(%) M(sd) or N(%)
Age (years) 52.4 (5.82) 52.4 (5.15) 52.1 (5.74) t = 0.470 0.639
Marital Status (yes)
Married 197 (65.7%) 68 (57.4%) 116 (63%) χ2 = 0.795 0.373
Cohabitation 18 (6%) 5 (31.2%) 11 (68.8%) χ2 = 0.112 0.738
Divorced 33 (11%) 9 (29%) 22 (71%) χ2 = 0.568 0.451
Widower 2 (0.7%) – – –
Not married 37 (12.3%) 9 (27.3%) 24 (72.7%) χ2 = 1.013 0.314
Other 12 (4%) 7 (58.3%) 5 (41.7%) χ2 = 2.964 0.085
In a relationship (yes) 259 (86.3%) 94 (38.8%) 148 (61.2%) χ2 = 11.067 0.001
Financial Status (yes)
Low income 96 (32.7%) 25 (27.5%) 66 (72.5%) χ2 = 3.471 0.062
Medium income 186 (63.3%) 71 (39.7%) 75 (60.3%) χ2 = 4.516 0.034
High income 12 (4.1%) 2 (22.2%) 7 (77.8%) χ2 = 0.679 0.410
Education (yes)
Elementary 39 (13.1%) 14 (40%) 21 (60%) χ2 = 0.417 0.518
Secondary 231 (77.5%) 77 (34.8%) 144 (65.2%) χ2 = 0.038 0.846
Higher 26 (8.7%) 7 (30.4%) 16 (69.6%) χ2 = 0.242 0.697
In the Last Month 1 (yes)
Alcohol 33 (89%) 6 (20.7%) 23 (79.3%) χ2 = 2.960 0.085
Cigarettes 50 (16.7%) 21 (42.9%) 28 (57.1%) χ2 = 2.837 0.092
Marijuana 4 (1.3%) – –
War deployment (months) 29.6 (19.2) 29.6 (19.34) 30 (19.51) t = −0.163 0.871
Cluster B symptoms 15 (3.25) 15.1 (2.92) 14.9 (3.32) t = 0.534 0.594
Cluster C symptoms 6.2 (1.47) 6.1 (1.48) 6.3 (1.46) t = −1.047 0.296
Cluster D symptoms 18.7 (5.15) 17.2 (4.81) 19.4 (5,06) t = −3.612 <0.001
Cluster E symptoms 17.7 (3.9) 16.9 (4.27) 18 (3.64) t = −2.422 0.016
Total PTSD symptoms 57.5 (10.92) 55.2 (10.46) 58.6 (10.71) t = −2.559 0.011
Relationship satisfaction 25.9 (6.37) 1 28.1 (5.15) 2 24.8 (6.01) 3 t = 4.298 <0.001
1 n = 256, range 7–35; 2 n = 148; 3 n = 98.
2.2. Measures
2.2.1. PTSD Checklist for DSM-5 (PCL-5) with Criterion A
The PCL-5 with Criterion A [29] is a self-report measure was revised to match the adapted DSM-5
criteria for PTSD. The interpretation of the PCL-5 should be made by a clinician. A PTSD diagnosis
can be made provisionally considering items rated 2 = moderately or higher as a symptom endorsed
according to the DSM-5 diagnostic rule (at least one B, one C, two D, and two E symptoms present).
DSM-5 symptom cluster severity scores can be obtained by summing the scores for the items within
a given cluster, i.e., cluster B (items 1–5), cluster C (items 6–7), cluster D (items 8–14), and cluster E
(items 15–20). A total symptom severity score (range 0–80) can be obtained by summing the scores
for each of the 20 items. Preliminary validation work was sufficient to make a cut-point score of
33, which was chosen for the purpose of this study [29]. Previous validation studies showed good
psychometric properties for evaluating PTSD [30–33]. Cronbach’s alpha in our study for clusters of
symptoms ranged from 0.67 to 0.85, and to 0.89 for total PCL-5. The Criterion A measure was included
in the assesment according the criteria of DSM-5 [16].
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2.2.2. The International Index of Erectile Function (IIEF)
IIEF [34] is a widely used, multi-dimensional self-report instrument for the evaluation of male
sexual function over the last four weeks [34]. It consists of 15 questions grouped into five domains
that assess erectile function (Q1,2,3,4,5,15), intercourse satisfaction (Q6,7,8), orgasmic function (Q9,10),
sexual desire (Q11,12), and overall satisfaction (Q13,14). Each item is rated from 1 (very low; almost
never or never; extremely difficult) to 5 (very high; almost always or always; not difficult). Scores for
domains are calculated as the sum of the answers, with lower scores indicating worse functioning.
The score for erectile function can be calculated and used to classify the severity of dysfunction as
severe, moderate, mild, or no dysfunction. For other domains, a higher score indicates better function.
The IIEF meets psychometric criteria for test reliability and validity, has a high degree of sensitivity
and specificity, and correlates well with other measures of treatment outcome [34–37]. Cronbach’s
alpha was 0.96 for erectile function, 0.91 for orgasmic function, 0.89 for sexual desire, and 0.91 for
intercourse satisfaction and overall satisfaction.
2.2.3. Premature Ejaculation Diagnostic Tool (PEDT)
PEDT [38,39] is a self-report instrument for the evaluation of the presence and severity of
premature ejaculation. Each PEDT item is rated from 0 (not difficult at all; almost never or never; not at
all) to 4 (extremely difficult; almost always or always, extremely), with a higher score indicating more
difficulties with premature ejaculation. Previous validation studies have shown satisfactory feasibility,
reliability, and validity of the PEDT [38,39]. Cronbach’s alpha for PEDT scale in our study was 0.87.
2.2.4. Male Sexual Dysfunction Criteria
The DSM-5 [16] classification recognizes four male sexual dysfunctions: delayed ejaculation (DE),
erectile disorder (ED), male hypoactive sexual desire (HSD), and premature (early) ejaculation. To be
diagnosed with SD, the symptoms must be present for at least six months, cause significant distress,
and not be caused exclusively by a non-sexual mental disorder, significant relationship distress, medical
illness, or medication. Also, these diagnoses are applicable to men who engage in non-vaginal sexual
activity, but unfortunately, the specific duration criteria remain unknown [16]. For the purposes of this
study, the following criteria were applied for a provisional diagnosis:
• DE—items Q9 or Q10 on IIEF rated 2 or less.
• ED—sum of scores on IIEF items Q1-Q5 and Q15 was 16 or less.
• HSD—items Q11 or Q12 on IIEF rated 2 or less.
• PE—item 2 on PEDT (Do you ejaculate before you want to?) rated 3 (Over half the time—>75%) or 4
(Always or Almost always—100%).
2.2.5. Relationship Assessment Scale (RAS)
The RAS [40,41] is a seven-item measure of global relationship satisfaction. Responses are on
a five-point Likert scale, and either the total or the average score can be used in the interpretation.
Average scores range from 1 to 5; total scores range from 7 to 35 (used in this study). Higher scores
indicate greater relationship satisfaction. The reliability and validity of the English RAS have been
established [41]. Cronbach’s alpha in our study was 0.87.
2.2.6. Mini-International Neuropsychiatric Interview (MINI)
Comorbid psychiatric disorders were diagnosed using the Croatian version of MINI for
DSM-IV [28]. It is a brief and valid structured clinical interview meeting the need for a short but
accurate structured psychiatric interview for multicenter clinical trials and epidemiology studies, to
be used as a first step in outcome tracking in nonresearch clinical settings. This interview enables
researchers to assess the 17 most common psychiatric disorders in DSM-IV.
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2.2.7. Anatomical Therapeutic Chemical (ATC) Classification System
Self-reported data about drug consumption are classified in accordance with the ATC
classification [42]. In brief, the ATC system classifies therapeutic drugs. The purpose of the system is
to serve as a tool for drug utilization research in order to improve the quality of drug use. In the ATC
classification system, the drugs are divided into different groups according to the organ or system on
which they act and their chemical, pharmacological, and therapeutic properties. Drugs are classified
into five different groups.
2.3. Data Analysis
2.3.1. Data Analysis Plan
The aim of the study was to assess the predictive models of several sexual dysfunctions in male
veterans with PTSD. Average score of erectile function, orgasmic function, sexual desire, intercourse
satisfaction, overall satisfaction (all measured by IIEF), and premature ejaculation (measured by
PEDT) were the outcome variables. Prediction variables were characteristics identified as relevant for
sexual dysfunction in previous studies. Two sets of hierarchical regression analyses were executed
for each of the sexual functions (one without and one with relationship satisfaction) in order to
assess the best models for the overall sample of veterans with PTSD and for the subset of veterans
in relationship. In order to control for covariances, predictor variables were entered in the following
steps/models: (1) sociodemographic variables, (2) comorbid disorders (psychiatric and others), (3)
medication used (psychotropic and other drugs), (4) variables related to PTSD (deployment duration
and PTSD symptoms), and (5) relationship satisfaction (subset sample of veterans in relationship).
The exclusion criterion for dichotomous predictors was set to 10 or less events per variable [43].
The inclusion criterion for a prediction variable was a significant association with the outcome variable.
2.3.2. Statistical Analysis
Statistical analysis was performed with Statistica software, version 12 (Dell Inc. Inc., Tulsa, OK,
USA). Data are presented as N (%) or M (sd). Chi-square tests for categorical variables and independent
sample t-tests for continuous variables were used to compare veterans with or without provisional
diagnosis of sexual dysfunction. Pearson and Spearman correlation coefficients were calculated
between sexual functions and the variables of interest. Several hierarchical multiple regressions were
performed to test for the best prediction models for the outcome variables of erectile function, orgasmic
function, sexual desire, intercourse satisfaction, overall satisfaction, and premature ejaculation. All
models were controlled for basic assumptions. Two issues with multicollinearity were encountered, i.e.,
between cluster D and cluster E symptoms with overall PTSD symptoms, and between in-a-relationship
status and relationship satisfaction in the subset sample. Overall PTSD symptoms were excluded from
both sets of samples, and the in-a-relationship status variable from the subset sample. Missing values
were controlled for listwise. Probability significance was set to p ≤ 0.05.
3. Results
3.1. Sociodemographic Data
Sociodemographic data for the overall sample are presented in Table 1.
3.2. Trauma Exposure and PTSD
The average duration of active participation in the Homeland war was 30 (19.516) months, ranging
from 1 month to 70 months.
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Twenty-three percent of participants had sought psychiatric help in the period from 1991 to 1995,
while the war was ongoing. The average intensity for overall PTSD symptoms was 57.5 (10.92) within
the range of 33 to 80. The average intensity of B symptoms was 15 (3.25), of C symptoms 6.2 (1.47), of
D symptoms 18.7 (5.15), and of E symptoms 17.7 (3.90).
3.3. Prevalence of SD and Association with Sociodemographic Data and PTSD
The average score for erectile function was 16 (9.71), which relates to moderate dysfunction.
The average score for orgasmic function was 5.8 (3.31) (theoretical maximum = 8), for sexual desire 5.8
(2.47) (theoretical maximum = 8), for intercourse satisfaction 6.51 (4.71) (theoretical maximum = 12),
and for overall satisfaction 6.3 (2.44) (theoretical maximum = 8). The average score for PEDT was 7.43
(5.14) within the range of 0 to 20.
According to provisional criteria for male sexual dysfunction (described in methodology), the
following rates were found: DE 124 (44%, n = 282), ED 134 (46.2%, n = 290), HSD 128 (44.6%, n = 287),
and PE 59 (21.3%, n = 277). Overall, on the basis of self-reported data, 98 (35.1%) of veterans with PTSD
did not meet, while 181 (64.9%) participants met provisional criteria for at least one male SD in the
last month. Out of possible four SD, one SD had 49 (17.6%) participants, two SDs had 36 participants
(12.9%) participants, three SD had 80 participants (28.7%), and four SD had 16 participants (5.7%).
As presented in Table 1, participants in a relationship and participants with medium income were
less likely to have a provisional diagnosis of SD. Participants who met the provisional diagnosis of SD
were significantly less satisfied with their relationship compared to participants without SD. Veterans
with SD had significantly greater severity of cluster D, cluster E, and overall symptoms of PTSD. They
did not differ for duration of deployment or for cluster B and cluster C symptoms.
Prevalence of comorbid disorders and drug use and association with SD are presented in
Supplementary Materials: Material S1.
3.4. Prediction Models of Sexual Dysfunctions among War Veterans with PTSD
Predictor variables for each model (i.e., sexual function) were selected on the basis of the following
criteria: variables with events greater than 10 and significant correlation with the outcome variable
(Table S2). However, some variables were included regardless, such as age and all clusters of PTSD
symptoms. Also, analysis showed great correlation coefficients between overall PTSD symptoms
intensity and cluster D and E symptom intensity (variance inflation factor (VIF) > 8). Because of
the multicollinearity issues, overall PTSD symptoms were not included in the models. The variable
“in a relationship” had high multicollinearity with relationship satisfaction (VIF > 8), and, therefore,
only relationship satisfaction was included in the models for the subset of veterans in a relationship.
The final steps for all tested models are presented in Supplementary material (Tables S3 and S4).
An overview of individual significant predictors for each sexual function is given in Tables 2 and 3.
Table 2. Overview of individual significant predictors in the final step of hierarchical regression
analysis for the overall sample.
Erectile Function OrgasmicFunction Sexual Desire
Inter-Course
Satisfaction
Overall
Satisfaction
Premature
Ejaculation
B β B β B β B β B β B β
In a relationship 7.69 0.28 ** 1.98 0.21 * 0.93 0.13 * 3.94 0.30 ** 1.17 0.15 * 1.99 0.13
Alcohol use dis. 1 −1.62 −0.13 * −1.47 −0.12 *
Diabetes mellitus 1.71 0.12 *
Hypertension, esse. 2 −3.99 −0.20 ** −0.98 −0.15 * −1.49 −0.15 ** −0.71 −0.14 *
Antidepressant −1.3 −0.06 −1.12 −0.15 ** −0.71 −0.14 * −0.36 −0.07
Cluster D symptoms −0.46 −0.24 ** −0.15 −0.23 ** −0.14 −0.29 ** −0.23 −0.25 ** −0.11 −0.23 ** 0.21 0.21 *
* p ≤ 0.05; ** p ≤ 0.01; 1 Alcohol use disorders; 2 Hypertension, essential; significant values are in bold.
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Table 3. Overview of individual significant predictors in the final step of hierarchical regression
analysis for the subset sample of veterans in a relationship.
Erectile Function OrgasmicFunction Sexual Desire
Inter-Course
Satisfaction
Overall
Satisfaction
Premature
Ejaculation
B β B β B β B β B β B β
Diabetes mellitus 1.91 0.14 *
Hypertension, esse. 1 −3.08 −0.17 ** −0.78 −0.12 * −0.84 −0.09 −0.48 −0.10
Hyperplasia prost. 2 −2.88 −0.05 −169 −0.08 −2.19 −0.08 −1.99 −0.13 *
Antidepressant −1.17 −0.06 −0.96 −0.15 * −0.73 −0.15 * −0.47 −0.11 *
Cluster D symptoms −0.38 −0.21 ** −0.15 −0.24 ** −0.14 −0.30 ** −0.11 −0.23 ** −0.09 −0.19 ** 0.23 0.23 **
Relationship satisf. 3 0.43 0.29 ** 0.14 0.28 ** 0.06 0.16 ** 0.27 0.39 ** 0.16 0.44 ** 0.05 0.07
* p ≤ 0.05; ** p ≤ 0.01; 1 Hypertension, essential; 2 Hyperplasia of prostate; 3 Relationship satisfaction; significant
values are in bold.
3.4.1. Erectile Function
The initial model tested for erectile function included age, low income, medium income, not
married, married, “in a relationship” status (Model 1: R2 = 0.134, F = 7.060, p < 0.001). In the second
step ongoing major depressive episode (MDE), panic disorder lifetime, essential hypertension, and
hyperplasia of prostate (Model 2: R2 = 0.181, F = 5.816, p < 0.001) were included; in the third step, use
of antidepressants, hypnotics, and sedatives (Model 3: R2 = 0.184, F = 5.514, p < 0.001) was added;
in the fourth step, war deployment in months and cluster B, C, D, and E symptoms were added (model
4: R2 = 0.257, F = 5.651, p < 0.001). Significant predictors did not change through the models. The final
model explained 25.7% of the variance of erectile function. Variables with significant independent
contribution were being in a relationship, having essential hypertension, and severity of D cluster
symptoms (Table 2).
In the subset of participants in a relationship, Model 1, containing age, low income, medium
income, not married, and married, was not significant, since the variable relationship status was
removed. Model 2 accounted for 9.3% (F = 2.200, p = 0.019), Model 3 for 9.98% (F = 2.097, p = 0.22),
and Model 4 for 20.1% (F = 3.273, p < 0.001) of the variance of erectile function. The final model with
relationship satisfaction added explained 27.9% of the variance of erectile function (F = 5.457, p < 0.001).
Significant individual predictors were having essential hypertension, severity of cluster D symptoms,
and relationship satisfaction. (Table 3).
3.4.2. Orgasmic Function
The initial model tested for orgasmic function included age, higher education, low income,
medium income, married, and “in a relationship” status (Model 1: R2 = 0.100, F = 4.619, p < 0.001).
In the second step, ongoing MDE, panic disorder lifetime, essential hypertension, hyperplasia of
prostate, and disorders of lipoprotein metabolism were added (Model 2: R2 = 0.165, F = 4.397, p < 0.001);
in the third step, use of antidepressants, hypnotics, and sedatives (Model 3: R2 = 0.189, F = 4.751,
p < 0.001) was included; in the fourth step, cluster B, C, D, and E symptoms (Model 4: R2 = 0.248,
F = 4.628, p < 0.001) were added. Higher education level was a significant individual contributor until
psychotropic medication was introduced in the third step. The final model explained 24.8% of the
variance of orgasmic function. Significant independent predictors were being in a relationship, use of
antidepressants, having hypertension, and severity of cluster D symptoms (Table 2).
In the subset of participants who were in a relationship, Model 1 was not significant and accounted
for 5.4% variance of orgasmic function. Model 2 (R2 = 0.121, F = 2.601, p = 0.004), Model 3 (R2 = 0.152,
F = 3.098, p < 0.001), and Model 4 (R2 = 0.244, F = 3.839, p < 0.001) were all significant. The final model
explained 29.5% of the variance of orgasmic function (F = 4.679, p < 0.001). Significant individual
predictors were: use of antidepressants, presence of essential hypertension, severity of cluster D
symptoms, and relationship satisfaction (Table 3). There was no significant change in the significance
of individual predictors through the models.
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3.4.3. Sexual Desire
The initial model for sexual desire included age, low and medium income, and “in a relationship”
status (Model 1: R2 = 0.055, F = 4.131, p = 0.003). In the second model, alcohol use disorder (AUD) was
added (Model 2: R2 = 0.074, F = 4.521, p = 0.001); in the third model, antidepressant use was included
(Model 3: R2 = 0.095, F = 4.901, p < 0.001); in the fourth model, cluster B, C, D, and E symptoms
(Model 4: R2 = 0.166, F = 5.482, p < 0.001) were added. All the models were significant, and there
was no change in the significance of individual predictors. The final model explained 16.6% of the
variance of sexual desire in the entire sample. Predictors with independent contribution were being
in a relationship, presence of an AUD, use of antidepressant, and severity of cluster D symptoms
(Table 2).
In the subset sample of veterans in a relationship, the sociodemographic variables entered did
not significantly contribute to the variance of sexual desire (Model 1: R2 = 0.035, F = 2.219, p = 0.068)
Addition of AUD in step two (Model 2: R2 = 0.054, F = 2.789, p = 0.018), antidepressant in step three
(Model 3: R2 = 0.081, F = 3.536, p = 0.002), and clusters of PTSD symptoms in step four (Model 4:
R2 = 0.172, F = 4.930, p < 0.001) significantly increased the variance of sexual desire. The final model
which included relationship satisfaction explained 19.6% of sexual desire in veterans in a relationship
(F = 5.227, p < 0.001). As in the total sample, predictors with significant independent contribution
were use of an antidepressant and severity of cluster D symptoms, but not AUD. A significant
contributor was also relationship satisfaction (Table 3). The significant predictors did not change
through the models.
3.4.4. Intercourse Satisfaction (IS)
The initial model for the intercourse satisfaction consisted of age, low income, medium income,
not married, divorced, married and relationship status (Model 1: R2 = 0.139, F = 6.748, p < 0.001).
In the second model, ongoing MDE, other anxiety disorders, essential hypertension, and hyperplasia
of prostate were added (Model 2: R2 = 0.168, F = 5.287, p < 0.001); in the third (final) model, war
deployment in months, cluster B, C, D, and E symptoms (Model 3: R2 = 0.251, F = 5.714, p < 0.001)
were included. There was no change in individual predictors through the models, and the final model
explained 25.1% of intercourse satisfaction in veterans with PTSD. The identified significant predictors
were being in a relationship, presence of essential hypertension, and severity of cluster D symptoms
(Table 2).
In the subset sample of veterans who were in a relationship, the final model accounted for 31.6%
of intercourse satisfaction (F = 7.382, p < 0.001). All tested models were significant (Model 1: R2 = 0.067,
F = 2.982, p = 0.008; Model 2: R2 = 0.102, F = 2.788, p = 0.003; Model 3: R2 = 0.188, F = 3.987, p < 0.001).
The significance of predictors did not change through the models. In contrast to the overall sample,
essential hypertension was not a significant predictor of IS among veterans in a relationship. Severity of
D cluster symptoms and relationship satisfaction were independent significant contributors (Table 3).
3.4.5. Overall Satisfaction
In the first model for overall satisfaction, the following variables were entered: age, low income,
medium income, and “in a relationship” status (Model 1: R2 = 0.061, F = 4.474, p = 0.002). In the next
step, comorbid diseases, ongoing MDE, panic disorder lifetime, other anxiety disorders, AUD, essential
hypertension, and hyperplasia of prostate were entered (Model 2: R2 = 0.140, F = 4.371 p < 0.001); in
the third step, use of antidepressants (Model 3: R2 = 0.145, F = 4.125, p < 0.001) was included; in the
fourth step, clusters B, C, D, and E symptoms (Model 4: R2 = 0.210, F = 4.652, p < 0.001) were added.
Recurrent panic disorder was a significant predictor until PTSD symptoms were entered in the last
step. The final model explained 21% of the variance of overall satisfaction in veterans with PTSD.
Significant individual predictors of overall satisfaction were being in a relationship, presence of an
AUD, presence of essential hypertension, and severity of cluster D symptoms (Table 2).
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All the models tested for overall satisfaction among veterans with PTSD who were in a relationship
were significant (Model 1: R2 = 0.038, F = 3.188, p = 0.024; Model 2: R2 = 0.117, F = 3.457, p < 0.001;
Model 3: R2 = 0.136, F = 3.717, p < 0.001; Model 4: R2 = 0.215, F = 4.570, p < 0.001). The “other anxiety
disorders” variable was a significant predictor until PTSD symptoms were entered in the fourth step.
The final model in the subset sample explained 38.4% of the variance of overall satisfaction (F = 9.651,
p < 0.001). Significant individual predictors were: presence of hyperplasia of prostate, use of an
antidepressants, severity of cluster D symptoms, and relationship satisfaction (Table 3). It is important
to note that relationship satisfaction by itself (β = 0.435) explained most of the variance of overall
sexual satisfaction.
3.4.6. Premature Ejaculation
In the first model of premature ejaculation in the overall sample, the following sociodemographic
variables were entered: age, not married, married, and “in a relationship” status (Model 1: R2 = 0.054,
F = 3.779, p < 0.01). In Model 2, diabetes mellitus (DM) was added (R2 = 0.067, F = 3.795, p < 0.01), and
cluster B, C, D, and E symptoms were added in Model 3. Significant individual predictors were DM
and severity of cluster D symptoms (Table 2).
Similar findings were reported in the subset sample of veterans in a relationship, as the final model
contributed to 10.7% of the variance of premature ejaculation (F = 3.019, p < 0.001) with the independent
significant contributors DM and cluster D symptoms (Table 3). Model 1, containing sociodemographic
variables (R2 = 0.016, F = 1.257, p = 0.290), and Model 2 (R2 = 0.035, F = 2.079, p = 0.054), containing
comorbid diseases, did not contribute significantly to the variance of premature ejaculation. Model
3, which included clusters of PTDS symptoms, was significant (R2 = 0.104, F = 3.277, p < 0.001).
Relationship satisfaction added in the final model did not alter significantly the variance explained.
4. Discussion
To the best of our knowledge, the present study is the first to suggest patterns of association of
PTSD with different types of SD and to determine the predictors of this relationship. The results of
the study support the main hypothesis that SD in veterans with PTSD are predicted by the severity
of the D cluster of PTSD symptoms. The second part of the hypothesis that states SD are predicted
by overall PTSD symptom severity is partially supported. We found that veterans with SD had
significantly higher PTSD symptom scores than veterans without SD. Furthermore, overall PTSD
symptom severity was significantly correlated with all types of SD (DE, ED, HSD, and PE) as well as
intercourse satisfaction (IS) and overall satisfaction (OS). Analysis revealed significant multicollinearity
of this predictor with D symptoms of PTSD, which implies that the association of PTSD symptom
severity with SD is mediated and mostly depends on the quantity and severity of trauma-related
negative alterations in cognition and mood. Previous studies found high rates of SD among male
veterans with PTSD [1–5]. The results of our study are consistent with the scarce but increasing body
of research that indicates that the severity of PTSD measured by overall scores on PTSD scales is not a
significant predictor of SD in veterans with PTSD [2,5,11,12].
Beside the prevalence and correlation of SD with PTSD, it is important to understand the
background of this relationship. A high score of D symptoms (Trauma-Related Negative Alterations in
Cognition and Mood) appears to be the most prevalent predictor of SD among veterans with PTSD,
emerging as a significant predictor of all types of SD (DE, ED, HSD, PE) as well as of IS and OS. D
cluster includes three new symptoms according to the DSM-5 classification: negative expectations
of self, others, or the world (replacing the sense of foreshortened future), persistent distorted blame
of self or other for trauma, and pervasive negative emotional state. The presence of these symptoms
and/or other symptoms from the D cluster, such as diminished interest or participation in significant
activities, a feeling of detachment or estrangement from others, or a persistent inability to experience
positive emotions, precludes a person’s capacity to engage adequately in sexual behavior(s). As a
result, D symptoms predict lower levels of satisfaction in sexual life. The current DSM-5 classification
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embraces the four-factor model, as it provides a better representation of PTSD’s latent structure than
the tripartite model of DSM-IV [43–46], which has received extensive criticism [47]. Our findings in
veterans are consistent with prior research demonstrating that avoidance/numbing symptoms of PTSD
are strongly linked to self-reported problems in sexual functioning. Nunnink and colleagues found
that self-reported symptoms of emotional numbing predicted a greater likelihood of endorsing sexual
problems [11]. The results of another study that investigated predictors of ED and self-reported sexual
problems among 150 male combat veterans seeking outpatient treatment for PTSD revealed, beside
various demographic, physical, and psychosocial risk factors, a significant zero-order correlation
between avoidance/numbing symptoms and SD [2].
Partner relationship is the next prominent predictor of SD in veterans with PTSD. Results in the
overall sample revealed that being in a partner relationship reduces the risk of DE, ED, HSD, IS, and
OS. Being in a relationship has no predictive value for PE. Analysis in the sample of participants who
were in a partner relationship indicated that a low level of relationship satisfaction was a significant
predictor of DE, ED, HSD, and IS and OS. Relationship satisfaction was not a significant predictor of PE.
The association of PTSD with impairments in romantic relationship satisfaction has been previously
reported [11,19,20]. A recent meta-analysis of 23 studies found an association between the emotional
numbing and avoidance symptom cluster and parent, child, family, and marital/partner functioning
problems [48]. Sexual functioning and relationship satisfaction are also robustly, positively correlated
in many different samples across a variety of adult populations, including those who are dating [49,50],
in long-term relationships [51], and married [52,53]. A lower level of relationship satisfaction in our
study sample was an independent predictor of SD and was not mediated by the severity of any PTSD
cluster. Sexual functioning is one of the essential domains of relationship functioning. Association
between SD and quality of relationship is bidirectional and reciprocal. Relationship problems caused
by family stressors, economic reasons, lifestyle, etc. inevitably affect sexual functioning. Problems
in sexual functioning may have an impact on all other domains of a relationship. In the context of
PTSD, the quality of a relationship also depends on the accommodation capacities of the partner for
mutual acceptance, which is important for healthy sexual functioning. Additionally, PTSD may affect
relationship and sexual functioning indirectly through changes of behavioral patterns. For example,
insomnia and nightmares are less likely to have a direct impact on sexual functioning than numbing
symptoms. On the other hand, these symptoms may lead to sleeping in separate beds, allowing or
encouraging the rituals and avoidant behavior that lessen the quality of a relationship and sexual
functioning. This finding implies that therapeutic efforts directed to promoting relationship satisfaction
in veterans with PTSD could have a positive effect on sexual functioning in most of its domains.
Interestingly, being in a relationship and relationship satisfaction are not significant predictors of PE.
This finding could be explained by considering PE symptoms as more of an individual than a relational
problem, which in turn is not worsened or maintained by disturbances in a partner relationship.
Antidepressant use is a significant predictor of the impairment of orgasmic functioning
and sexual desire, i.e., veterans with PTSD that use antidepressants have increased risk for DE
and HSD. Surprisingly, antidepressant utilization did not show predictive values for ED and
OS. Adverse sexual effects are frequent with commonly prescribed psychotropic drugs and are
usually underestimated [24,54]. The recent clinical guidelines highlight antidepressants as first-line
pharmacotherapeutic agents in the management of PTSD [55,56]. In spite of increasing rates of drug
utilization (80%) among veterans with PTSD [57], some studies revealed a marked inconsistency with
the current guidelines for treatment of PTSD, particularly in the post-conflict settings [58]. In that
context, our finding of antidepressant use as a significant predictor of DE and HSD is important,
bearing in mind that 41.5% of our participants have DE and 45.4% have HSD. The findings are
consistent with a meta-analysis which revealed increased rates of SD among patients in treatment
with antidepressants [54]. Furthermore, higher rates of total and specific-treatment emergent SD
and specific phases of dysfunction were found for drugs with a predominantly serotonergic action,
including selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake
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inhibitors (SNRIs) [55,59]. Ejaculation-delaying effect of antidepressants on orgasmic function is,
on the other hand, the basis for the use of either tricyclic antidepressant or SSRIs in treatment of
PE. Among other medications from this pharmacological group, paroxetine has the most prominent
ejaculation-delaying effect [60] caused by its impact on serotonergic receptors, cholinergic receptor
blockade, and inhibition of nitric oxide synthase [61–64]. It is also supported by the results of this
study, as antidepressants are not significant predictors of PE.
Arterial hypertension was a significant predictor of ED, DE, IS, and OS in the overall sample.
It was a significant predictor of ED and DE in the sample of veterans in a relationship. These findings
are consistent with those of numerous studies that emphasize high blood pressure as a risk factor
for SD [65–67]. Actually, vasculogenic ED is considered part of a systemic vasculopathy and has a
known relationship with cardiovascular risk factors such as hypertension, diabetes, dyslipidemia,
and smoking [68]. A research that included 1255 male participants revealed that lower systolic and
diastolic blood pressure were associated with better sexual functioning [67].
The significant predictor of PE in the overall sample and among participants in a relationship was
DM. Patients with DM have higher rates of various SD directly related to the deleterious complications
of their disease. [69–71]. DM is also indirectly related to SD through anxiety and depression that
are often experienced by men with DM [72]. Of these, ED was most commonly reported [69–71].
Some studies reported higher rates of PE in patients with DM, indicating duration, severity, and
poor metabolic control as the main risk factors for PE in diabetic patients. On the other hand,
a close relationship between ED and PE exists. Some authors suggest that the longer the erectile
problem, the worse the anxiety, and the more marked the PE [73]. Because of performance anxiety
regarding their erectile reliability, patients could rush through an intercourse, with PE as a deleterious
consequence [74].
AUD was a significant predictor of SD and OS in the overall sample and in those who patients
were in a relationship. The results are consistent with the findings of a previous research and
meta-analysis [65]. This finding is important in the context of populations of veterans with PTSD, as
repeated heavy drinking is one of the common strategies to alleviate trauma symptoms that may lead
to the development of AUD. The prevalence of AUD in PTSD is also high. For example, in the US,
42% of PTSD subjects met criteria for AUD diagnosis [75]. The prevalence of alcohol-induced sexual
dysfunction is unclear, probably because of underreporting. Sexual disorders ranging from 8% to
95.2% have been reported in men with chronic alcohol use [76–80]. The common dysfunctions reported
were lack of sexual desire [79,80], premature ejaculation [81,82], and erectile dysfunction [76,82–84].
Although the prevalence of the SD was not the main focus of this research, it is indicative that
none of the participants reported being diagnosed with SD. Only one veteran with PTSD reported the
utilization of a medication prescribed to treat ED (sildenafil). This finding is completely inconsistent
with data from previous studies suggesting that SD is strongly related to PTSD, particularly war-related
PTSD [1–5]. A backup check of medical records confirmed only one diagnosis of SD recorded in the
study sample. Two widely used instruments for the assessment of the presence and severity of the
different types of SD were applied with restrictive criteria for severity of SD symptoms, consistent with
DSM-5 for diagnosis of SD (i.e., present in at least 75% of sexual activity occasions) in order to avoid
over-diagnosing minor and potentially transient problems in sexual functioning. According to that
criteria, the following rates were found: SD in 64.9% of patients, DE in 44%, ED in 46.2%, HSD in 44.6%,
PE in 21.3%. The rates of SD differ across studies [6–10], mainly because of different methodological
approaches. Predominantly, two methods for identifying SD have been used in research. In some
studies, the estimation of SD diagnosis was based on reported patients’ symptoms and problems
in sexual functioning, with wide criteria for SD applied. In another study, the presence of SD was
considered if SD diagnosis was recorded or medication for SD was used, which may be a more
conservative approach. Both methods for identifying SD may be problematic. If we chose the second
approach, we could conclude that veterans with PTSD in our sample had superior sexual functioning.
Therefore, we chose the first approach, bearing in mind that self-reported symptoms in questionnaires
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can be used only for an estimation and provisional diagnosis of SD. Clinical interviews are irreplaceable
and necessary to sufficiently diagnose SD if they are conducted by well-trained personnel, who are
also trained about social stigmatization. Conversely, they may contribute to underreporting biases
arising from personal concerns about social stigmatization and lack of privacy, particularly in older
or less educated participants [85]. The rates of SD in this study confirm that the complete absence of
SD diagnosis in our clinical setting could not be a consequence of non-clinically significant problems
among veterans. A dramatically higher self-reported prevalence of SD suggests a number of veterans
may be choosing not to disclose problems in sexual functioning with their healthcare providers because
of embarrassment, discomfort, or lack of knowledge about treatment possibilities.
4.1. Strenghts
This study was primarily designed to assess SD in the population of veterans with PTSD. Veterans
with PTSD were included regardless of their relationship status, as even those not in a current romantic
relationship may engage in sexual behavior and are often overlooked in studies. Data related to military
deployment, sociodemographic and relationship factors, psychiatric comorbidity, psychotropic and
other medication, and medical conditions were systematically collected, as all these factors could be
important contributors to SD. PTSD symptoms were assessed jointly, but, more importantly, the impact
of each cluster of PTSD symptoms (according to DSM-5 classification) on sexual functioning was also
assessed. In assessing SD, we applied a comprehensive approach covering a broader range of possible
sexual health problems as well as perceived sexual satisfaction.
4.2. Limitations
This study has several limitations. Findings from this study may not be reflective of and
generalisable to the broader veteran or nonveteran population. Because of the many variables
tested, data analysis suffered from multiple comparisons, allowing for possible false positive
effects/predictors. Health-care-seeking participants could suffer from more serious problems in
each area covered by the research. Furthermore, the generalisability is limited by a gender-imbalanced
sample, as only male veterans were included in the research. Because of the cross-sectional design, the
temporality of the relationship between the different studied variables and sexual dysfunction could
not be evaluated. The findings were based on self-reported symptoms from questionnaire measures.
Self-reports of sexual activity and satisfaction may be under- or overreported because of stigmatization.
5. Conclusions
One of the most salient implications of the current study is the importance of sexual health
assessment in veterans with PTSD. This study represents an advancement in our currently limited
understanding of patterns of association of PTSD with different types of SD and of the predictors of
that relationship. As veterans with PTSD are more likely to suffer from SD if they experience more
D symptoms and if they are not in a relationship or are less satisfied with the relationship, future
research should develop therapeutic interventions more focused on the negative appraisals, emotional
numbness, and irritability and other negative cognitions and emotions, as well as interventions
intended to improve relationship functioning with the aim to lessen the rates of SD in this population.
Psychotherapy is strongly recommended as the first-line treatment approach in PTSD. Sex therapy is
effective in the variety of the SD, and couple psychotherapy is an established approach for relationship
problems and dissatisfaction. Psychotherapeutic treatments, which would comprehensively cover
different aspects of the problems in patients with PTSD and SD comorbidity, could have greater
compliance rates, less iatrogenic adverse effects, and better treatment effects. Psychotropic treatment
with fewer adverse sexual effects and management of the treatment-emergent side effects are of utmost
importance if pharmacotherapy is applied. Medical conditions, particularly those stress-related and
frequent in study populations with diabetes and hypertension, carry an additional burden of increased
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risk for SD. Appropriate prevention, screening for those conditions, and their active treatment could
improve the sexual life of veterans with PTSD.
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